The company has successfully completed the first three cohorts of its Phase II study ... the fourth cohort currently ongoing. This progress demonstrates a robust pipeline that is advancing towards ...

This cohort-based program is a two-year experience that helps educators work to identify and design their own projects to ...

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

In getting his degree and then becoming licensed, Tracy succeeded by trying again and again. His background as a non-traditional student is one that he hopes will give his own students a sense of ...

To fully understand the potential link of the bacteria listed, alterations in research design and execution are required. The ...

Four Baylor University students have been selected as University Innovation Fellows, a nationally competitive global program ...

Fully enrolled the Phase 2/3 trial of lead asset CTX-009 (DLL4 and VEGF-A bispecific antibody) in patients with biliary tract cancers (BTC); ...

A new precision phenotyping algorithm offers improved accuracy in identifying long COVID patients, providing valuable ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good morning. My name is Alan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx ...